The FDA's Reluctance and Negative Impact on Drug Approval

This chapter explores the negative impact of the FDA's delays in approving contraceptives and COVID-19 tests, driving up prices and preventing the introduction of potentially beneficial medications. The speaker emphasizes the need to eliminate barriers to accessing necessary medicines.